Argitalpenak (50) Ikertzaileren baten partaidetza izan duten argitalpenak

2004

  1. Analyzing Sleep Abnormalities in HIV-Infected Patients Treated with Efavirenz

    Clinical Infectious Diseases, Vol. 38, Núm. 3, pp. 430-432

  2. Are fusion inhibitors active against all HIV variants?

    AIDS Research and Human Retroviruses, Vol. 20, Núm. 3, pp. 347-348

  3. Avances en el diagnóstico y tratamiento de la infección por el virus de la hepatitis B

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 9, pp. 539-549

  4. Benefits in the lipid profile after substitution of abacavir for stavudine: A 48-week prospective study

    AIDS Research and Human Retroviruses, Vol. 20, Núm. 12, pp. 1289-1292

  5. CD38 Expression on CD8+ T Lymphocytes as a Marker of Residual Virus Replication in Chronically HIV-Infected Patients Receiving Antiretroviral Therapy

    AIDS Research and Human Retroviruses, Vol. 20, Núm. 2, pp. 227-233

  6. Care of patients with hepatitis C and HIV co-infection

    AIDS, Vol. 18, Núm. 1, pp. 1-12

  7. Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 20, Núm. 3, pp. 271-273

  8. Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: Consensus recommendations

    AIDS, Vol. 18, Núm. 8, pp. 1137-1146

  9. Combinations of nucleoside/nucleotide analogues for HIV therapy

    AIDS Reviews, Vol. 6, Núm. 4, pp. 234-243

  10. Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals

    Journal of Virological Methods, Vol. 121, Núm. 1, pp. 115-118

  11. Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?

    AIDS Reviews, Vol. 6, Núm. 3, pp. 169-180

  12. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

    AIDS, Vol. 18, Núm. 8, pp. 1109-1116

  13. Different Viral Rebound following Discontinuation of Antiretroviral Therapy in Cases of Infection with Viruses Carrying L74V or Thymidine-Associated Mutations

    Journal of Clinical Microbiology, Vol. 42, Núm. 2, pp. 862-866

  14. Efficient fuzzy compiler for SIMD architectures

    Applied Soft Computing Journal, Vol. 4, Núm. 3, pp. 287-301

  15. El control estatal de las entidades religiosas a través de los registros. López-Sidro López, Ángel

    Anuario de derecho eclesiástico del Estado, Núm. 20, pp. 610-613

  16. El milagro económico irlandés: un ejercicio de contabilidad del crecimiento mediante un modelo en desequilibrio en tiempo continuo

    Documentos de trabajo de economía aplicada, Núm. 1, pp. 1-26

  17. Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea

    AIDS, Vol. 18, Núm. 9, pp. 1251-1261

  18. Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes

    Clinical Infectious Diseases, Vol. 39, Núm. 8, pp. 1231-1238

  19. Evolution of genotypic and phenotypic resistance to enfuvirtide in HIV-infected patients experiencing prolonged virologic failure

    Journal of Medical Virology, Vol. 74, Núm. 1, pp. 21-28

  20. Exámen de las relaciones entre la Santa Sede y el Estado español: desde el concordato de 1953 a los acuerdos de 1979

    Cuadernos de derecho judicial, Núm. 11, pp. 89-162